Keywords: Boehringer Ingelheim, Combivent Respimat, Inhalation, USA, FDA, COPD

Boehringer Ingelheim’s Combivent Respimat Inhalation Spray OKed in USA to replace aerosol

Article | 09 October 2011

Print This

The US Food and Drug Administration has approved German independent drug major Boehringer Ingelheim’s Combivent Respimat (ipratropium bromide ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in